EMILIA PELUSO: Open Payments
NPI 1669846341 · LIVERPOOL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$230 in 9 payments from 7 companies in 2025. Trend: 2023 $309 · 2024 $0 · 2025 $230
Food & beverage: $230
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 3 | $76 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| GENZYME CORPORATION | 1 | $32 |
| Amgen Inc. | 1 | $27 |
| Octapharma USA, Inc. | 1 | $25 |
| Galderma Laboratories, L.P. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
Products named: Rhapsido, DUPIXENT, AYVAKIT, TEZSPIRE, PANZYGA, XOLAIR, NEMLUVIO, NEFFY.
Industry payments across NY — which companies pay providers there.
